Alterola Biotech, Inc. (ALTA) financial statements (2020 and earlier)

Company profile

Business Address 340 S. LEMON AVE., #4041
WALNUT, CA 91789
State of Incorp.
Fiscal Year End September 30
SIC 10 - Metal Mining (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

3/31/2018
TTM
9/30/2017
9/30/2016
9/30/2015
9/30/2014
9/30/2013
9/30/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments   3 9 
Cash and cash equivalents   3 9 
Prepaid expense     13
Advance royalties 11    
Other undisclosed current assets     1 
Total current assets: 113 23 
Noncurrent Assets
Other undisclosed noncurrent assets   6 6 
Total noncurrent assets:   6 6 
Other undisclosed assets  2 6 6
TOTAL ASSETS: 1386296
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 211138352420
Accrued liabilities 211138352420
Debt 66663030
Due to related parties   11  
Other undisclosed current liabilities 26824920617012671
Total current liabilities: 295267250212180121
Noncurrent Liabilities
Long-term debt and lease obligation 30 3030  
Long-term debt, excluding current maturities 30 3030  
Total noncurrent liabilities: 30 3030  
Total liabilities: 325267280242180121
Stockholders' equity
Stockholders' equity attributable to parent (295)(264)(241)(205)(150)(115)
Common stock 11511511511511578
Additional paid in capital 170133133133133133
Accumulated deficit (580)(512)(489)(453)(398)(326)
Total stockholders' equity: (295)(264)(241)(205)(150)(115)
Other undisclosed liabilities and equity   (30)(30)  
TOTAL LIABILITIES AND EQUITY: 30386296

Income statement (P&L) ($ in thousands)

3/31/2018
TTM
9/30/2017
9/30/2016
9/30/2015
9/30/2014
9/30/2013
9/30/2012
Gross profit:    (18)(3) 
Operating expenses (49)(15)(20)(41)(59)(4)
Other operating income (expense), net
(Other Expenses)
   (16)(14)1310
Other undisclosed operating income (loss)   1632(11)(10)
Operating loss: (49)(15)(20)(41)(59)(4)
Nonoperating expense
(Other Nonoperating expense)
 (19)(8)    
Interest and debt expense (19)(8)(16)(14)(10)(10)
Net loss: (86)(30)(36)(55)(70)(13)
Other undisclosed net loss attributable to parent     (3) 
Net loss attributable to parent: (86)(30)(36)(55)(73)(13)
Preferred stock dividends and other adjustments (37)     
Other undisclosed net income available to common stockholders, basic 568    
Net loss available to common stockholders, diluted: (68)(23)(36)(55)(73)(13)

Comprehensive Income ($ in thousands)

3/31/2018
TTM
9/30/2017
9/30/2016
9/30/2015
9/30/2014
9/30/2013
9/30/2012
Net loss: (86)(30)(36)(55)(70)(13)
Comprehensive loss, net of tax, attributable to parent: (86)(30)(36)(55)(70)(13)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: